Medicines Co scores FDA OK for new antibiotic, now up on the auction block
The Medicines Company’s infectious disease business just got more valuable.
The FDA has come through with an accelerated approval of Vabomere — the combo of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
